Fresenius Se Co Stock Price To Earnings To Growth
| FRE Stock | EUR 33.80 0.40 1.20% |
Fresenius SE Co fundamentals help investors to digest information that contributes to Fresenius' financial success or failures. It also enables traders to predict the movement of Fresenius Stock. The fundamental analysis module provides a way to measure Fresenius' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresenius stock.
Fresenius |
Fresenius SE Co Company Price To Earnings To Growth Analysis
Fresenius' PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Fresenius Price To Earnings To Growth | 1.00 X |
Most of Fresenius' fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius SE Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Fresenius SE Co has a Price To Earnings To Growth of 0.9953 times. This is 40.18% higher than that of the Healthcare sector and 19.92% higher than that of the Medical Care industry. The price to earnings to growth for all Germany stocks is 79.65% higher than that of the company.
Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
Fresenius Fundamentals
| Return On Equity | 0.0793 | |||
| Return On Asset | 0.0292 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 41.49 B | |||
| Shares Outstanding | 563.24 M | |||
| Shares Owned By Insiders | 26.90 % | |||
| Shares Owned By Institutions | 36.15 % | |||
| Price To Earning | 13.18 X | |||
| Price To Book | 0.70 X | |||
| Price To Sales | 0.36 X | |||
| Revenue | 37.52 B | |||
| Gross Profit | 10.26 B | |||
| EBITDA | 4.16 B | |||
| Net Income | 1.82 B | |||
| Cash And Equivalents | 1.46 B | |||
| Cash Per Share | 2.63 X | |||
| Total Debt | 27.16 B | |||
| Debt To Equity | 105.90 % | |||
| Current Ratio | 1.08 X | |||
| Book Value Per Share | 37.96 X | |||
| Cash Flow From Operations | 5.08 B | |||
| Earnings Per Share | 2.78 X | |||
| Price To Earnings To Growth | 1.00 X | |||
| Target Price | 13.74 | |||
| Number Of Employees | 319.69 K | |||
| Beta | 1.08 | |||
| Market Capitalization | 14.19 B | |||
| Total Asset | 71.96 B | |||
| Working Capital | 2.69 B | |||
| Current Asset | 11.13 B | |||
| Current Liabilities | 8.45 B | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 0.98 % | |||
| Net Asset | 71.96 B | |||
| Last Dividend Paid | 0.92 |
About Fresenius Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius SE Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius SE Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Fresenius Stock
Fresenius financial ratios help investors to determine whether Fresenius Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fresenius with respect to the benefits of owning Fresenius security.